Intestine-Specific, Oral Delivery of Captopril/Montmorillonite: Formulation and Release Kinetics

Nanoscale Research Letters

Volumn 6, Issue 1, 2011, Pages 1-8

  Madurai, Suguna Lakshmi ^a   Joseph, Stella Winnarasi ^a   Mandal, Asit Baran ^a   Tsibouklis, John ^b   Reddy, Boreddy S R ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Captopril montmorillonite; Intercalation; Intestine specific controlled release; Release kinetics

Indexed keywords

CLAY MINERALS; INTERCALATION; KINETICS; TARGETED DRUG DELIVERY; DRUG DELIVERY;

CONTROLLED RELEASE; DRUG DELIVERY SYSTEM; LOADING CAPACITIES; MONTMORILLONITE (MMT); ORAL DELIVERY; RELEASE KINETICS; ZERO-ORDER RELEASE;

CONTROLLED DRUG DELIVERY; CLAY MINERALS;

EID: 79952697771     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1007/s11671-010-9749-0     Document Type: Article

References (30)

1. Ferguson RK, Brunner HR, Turini GA, Gavras H, McKinstry DN: Lancet. 1977, 1: 775.
2. Ondetti MA, Rubin B, Cushman DW: Science. 1977, 196: 441.
3. Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Guttelod S, Gavras I, Ukovish RA, McKinstry DN: New Engl J Med. 1978, 298: 991.
4. Bravo EL, Tarazi RC: Hypertension. 1979, 1: 39.
5. Brunner HR, Gavras H, Waebar B, Kershaw GR, Turini GA, Vukovish RA, McKinstry DN: Ann Intern Med. 1979, 90: 19.
6. Testa MA, Anderson RB, Nackley JF, Hollenberg NK: New Engl J Med. 1993, 328: 907.
7. Antonaccio MJ: Ann Rev Pharmacol Toxicol. 1982, 22: 57.
8. Komai T, Ikeda T, Kawai K, Kameyama E, Shendo H: J Pharmacobio-Dynam. 1981, 4: 677.
9. Seta Y, Higuchi F, Kawahara Y, Nishimura K, Okada R: Int J Pharm. 1988, 41: 245.
10. Anaizi NH, Swenson C: Am J Hosp Pharm. 1993, 50: 486.
11. Horovitz SP: Angiotensin Converting Enzyme Inhibitors, Mechanisms of Action and Clinical Implications: Procceedings of the A. N. Richards Symposium Sponsored by the Physiological Society of Philadelphia. Urban & Schwarzenberg, Baltimore-Munich; 1981.
12. Miazaki N, Shionoiri H, Uneda S, Uneda G, Yasuda G, Gotoh E, Fujishima S, Kaneko Y, Kawahara Y, Yamazaki Y: Nippon Jinzo Gakkai Shi. 1982, 24: 421.
13. Migdalof BH, Wong KK, Lan SJ, Kripalani KJ, Singhvi SM: Fed Proc. 1980, 39: 757.
14. Drost JD, Reier GE, Jain NB: U. S. Patent 4756911. 1988.
15. Guittard GV, Carpenter HA, Quan ES, Wong PS, Hamel LG: US patent 5178867. 1993.
16. Nahata MC, Morosco RS, Hipple TF: Am J Hosp Pharm. 1994, 51: 95.
17. Joshi YM, Bachman WR, Jain NB: European Patent EP 288732 A2. 1988.
18. Thakur AB, Jain NB: U. S. Patent 4738850. 1988.
19. AprRashid A: British Patent Application 2230441A. 1990.
20. Singh J, Robinson DH: Drug Dev Ind Pharm. 1988, 14: 545.
21. Matharu RS, Singhavi NM: Drug Dev Ind Pharm. 1992, 18: 1567.
22. DeCrosta MT, Jain NB, Rudnic EM: U. S. Patent 4666705. 1987.
23. Sposito G, Skipper NT, Sutton R, Park SH, Soper AK, Greathouse JA: Proc Natl Acad Sci. 1999, 96: 3358.
24. Bergaya F, Theng BKG, Lagaly G: Handbook of clay science. Elsevier publication, Amsterdam; 2006.
25. Ghanshyam VJ, Hasmukh AP, Bhavesh DK, Hari CB: Appl Clay Sci. 2009, 45: 248.
26. Peppas NA, Sahlin JJ: Int J Pharm. 1989, 57: 169.
27. Reed-Hill RE, Abbaschain R: Physical metallurgy principles. 3rd edition. PWS publishing Company, Boston; 1994.
28. Suguna Lakshmi M, Sriranjani M, Bava Bakrudeen H, Suresh Kannan A, Mandal AB, Reddy Boreddy SR: Appl Clay Sci. 2010, 48: 589.
29. Pradhan R, Budhathoki U, Thapa P: J Sci Eng Technol. 2008, 1: 55.
30. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA: Int J Pharm. 1983, 15: 25.